Track topics on Twitter Track topics that are important to you
Awards recognise outstanding leaders and innovators in the life sciences sector in the North of England
Keele, UK, 4th December 2017: Cobra Biologics Ltd, an international CDMO of biologics and pharmaceuticals, is very proud to have been named as Company of the Year as well as being presented with the Technical Service Award in this year’s Bionow Awards. Now in their 16th year, the prestigious awards recognise excellence, outstanding achievement and enterprise in a sector that is worth £11bn to the North’s economy and are sponsored by Manchester Science Partnerships, Appleyard Lees and World Courier. The awards ceremony and gala dinner held on 30th November was attended by more than 400 people at The Mere Golf Resort & Spa in Knutsford, Cheshire.
Cobra secured the Technical Service Award for delivery of technical services related to the process development and manufacture of plasmid DNA for gene therapy products in clinical trials. This is an area where Cobra has seen a significant increase in worldwide demand with 99% of its customers located outside of the UK. The award, sponsored by Gateley Plc, was judged on the degree of innovation, impact and quality of the service.
The much sought-after Bionow Company of the Year Award, sponsored by AstraZeneca, was presented to Cobra’s Chief Executive Peter Coleman at the close of the ceremony, who was delighted to accept the ‘by invitation only’ award on behalf of Cobra’s dedicated staff.
Sarah Davies, GMP Production Manager, was also named runner up in the Bionow Promising Technologist of the Year category sponsored by Seqirus for her work in overseeing the technology transfer of a viral vector process from a small scale non-GMP third party manufacturer to reach in-market commercial supply.
Peter Coleman, Chief Executive of Cobra Biologics, said: “I am very proud of Cobra and what it has achieved over the last few years. Our team has worked incredibly hard to get to where we are now and as a result, we have a bright and promising future. Winning two Bionow Awards, including the prestigious Company of the Year award, is a fantastic end to a successful 2017.
“Being a finalist in the Promising Technologist category is such an achievement for Sarah Davies and she is a great example of how Cobra work’s alongside its customers to meet the needs of patients worldwide.”
About Cobra Biologics
Cobra Biologics is a leading international contract development and manufacturing organisation (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply.
Cobra has three GMP approved facilities in Sweden and the UK, each with expertise tailored to serving our customers around the world. We offer a broad range of integrated and stand-alone contract development and manufacturing services for clinical trials and the commercial market.
As a trusted provider and a key partner in the drug development and commercialisation process, we take pride in our manufacturing excellence and comprehensive range of services to the pharmaceutical and biotech industries. For more information please visit: www.cobrabio.com
A not-for-profit membership organisation, Bionow supports the North of England’s burgeoning life sciences sector, which currently includes some 1,000 science and healthcare companies with a combined turnover of around £10.9bn. Its member base includes start-ups and spin-outs as well as well-established businesses. The services it offers to firms include dedicated business support programmes, shared procurement schemes and recruitment and training support. For more information visit: www.bionow.co.uk
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...